These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39126245)

  • 1. O-GlcNAcylation determines the function of the key O-GalNAc glycosyltransferase C1GalT1 in bladder cancer.
    Jiang Y; Wu J; Guan F; Liang L; Wang Y
    Acta Biochim Biophys Sin (Shanghai); 2024 Aug; 56(8):1108-1117. PubMed ID: 39126245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC35A2 deficiency reduces protein levels of core 1 β-1,3-galactosyltransferase 1 (C1GalT1) and its chaperone Cosmc and affects their subcellular localization.
    Wiertelak W; Chabowska K; Szulc B; Zadorozhna Y; Olczak M; Maszczak-Seneczko D
    Biochim Biophys Acta Mol Cell Res; 2023 Jun; 1870(5):119462. PubMed ID: 36933771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3/ miR-1-3p axis in bladder cancer.
    Tan Z; Jiang Y; Liang L; Wu J; Cao L; Zhou X; Song Z; Ye Z; Zhao Z; Feng H; Dong Z; Lin S; Zhou Z; Wang Y; Li X; Guan F
    J Exp Clin Cancer Res; 2022 Jul; 41(1):228. PubMed ID: 35864552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
    Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
    Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1GALT1 in health and disease.
    Sun X; Zhan M; Sun X; Liu W; Meng X
    Oncol Lett; 2021 Aug; 22(2):589. PubMed ID: 34149900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
    Hung JS; Huang J; Lin YC; Huang MJ; Lee PH; Lai HS; Liang JT; Huang MC
    Oncotarget; 2014 Apr; 5(8):2096-106. PubMed ID: 24758762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate O-glycosylation actively regulates extracellular proteolysis.
    Madzharova E; Sabino F; Kalogeropoulos K; Francavilla C; Auf dem Keller U
    Protein Sci; 2024 Aug; 33(8):e5128. PubMed ID: 39074261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.
    Chou CH; Huang MJ; Chen CH; Shyu MK; Huang J; Hung JS; Huang CS; Huang MC
    Oncotarget; 2015 Mar; 6(8):6123-35. PubMed ID: 25762620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1 mimics the effect of IL-4 on the glycosylation of IgA1 by downregulating core 1 β1, 3-galactosyltransferase and Cosmc.
    Xiao J; Wang M; Xiong D; Wang Y; Li Q; Zhou J; Chen Q
    Mol Med Rep; 2017 Feb; 15(2):969-974. PubMed ID: 28035353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1GALT1-mediated O-glycan T antigen increase enhances the migration and invasion ability of gastric cancer cells.
    Bao X; Yu H; Chen Z; Chen W; Xiao Y; Wu X; Li Z
    Biochem Biophys Res Commun; 2024 Nov; 734():150641. PubMed ID: 39243676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
    Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
    Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cosmc-dependent mucin-type
    Stotter BR; Talbot BE; Capen DE; Artelt N; Zeng J; Matsumoto Y; Endlich N; Cummings RD; Schlondorff JS
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F518-F530. PubMed ID: 31904283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsp90 regulates O-linked β-N-acetylglucosamine transferase: a novel mechanism of modulation of protein O-linked β-N-acetylglucosamine modification in endothelial cells.
    Zhang F; Snead CM; Catravas JD
    Am J Physiol Cell Physiol; 2012 Jun; 302(12):C1786-96. PubMed ID: 22496241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for the Detection, Study, and Dynamic Profiling of O-GlcNAc Glycosylation.
    Thompson JW; Griffin ME; Hsieh-Wilson LC
    Methods Enzymol; 2018; 598():101-135. PubMed ID: 29306432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
    Chugh S; Barkeer S; Rachagani S; Nimmakayala RK; Perumal N; Pothuraju R; Atri P; Mahapatra S; Thapa I; Talmon GA; Smith LM; Yu X; Neelamegham S; Fu J; Xia L; Ponnusamy MP; Batra SK
    Gastroenterology; 2018 Nov; 155(5):1608-1624. PubMed ID: 30086262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on enhanced O-glycosylation strategy for improved production of recombinant human chorionic gonadotropin in Chinese hamster ovary cells.
    Deng Z; Yi X; Chu J; Zhuang Y
    J Biotechnol; 2019 Dec; 306():159-168. PubMed ID: 31604106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core 1 O-N-acetylgalactosamine (O-GalNAc) glycosylation in the human cell nucleus.
    Cejas RB; Garay YC; de la Fuente S; Lardone RD; Irazoqui FJ
    Biol Chem; 2020 Aug; 401(9):1041-1051. PubMed ID: 32297877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.
    Lin MC; Chien PH; Wu HY; Chen ST; Juan HF; Lou PJ; Huang MC
    Oncogene; 2018 Oct; 37(43):5780-5793. PubMed ID: 29930379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.